"Customers tell us that Digene's test suffers from many challenges, and Third Wave's dedicated team of scientists has developed HPV products, currently in clinical trials, that address those shortcomings and better meet the needs of clinical labs, physicians and their patients," Mr. Conroy said. "Third Wave remains firmly committed to delivering choices to physicians and women for detecting high-risk HPV infections."